TokenPost topic

Crescent Biopharma

1 TokenPost story is tagged Crescent Biopharma. The newest appear first.

Latest Crescent Biopharma stories

• Crescent Biopharma Posts $37.7 Million Q3 Loss as R&D Costs Rise

  The net loss widened from $24.607 million a year earlier, while the per-share loss narrowed to $0.90. Crescent had $289.4 million in cash at quarter-end.

  Nov 13, 2026, 8:35 AM EST · Business